The pretreatment of E. coli endotoxin shock with WR 2823: a new alpha-adrenergic blocking agent.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000818:Animals; D001794:Blood Pressure; D002302:Cardiac Output; D004285:Dogs; D004926:Escherichia coli; D005021:Ethylamines / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects*; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use; D010756:Phosphoric Acids / Q000627:therapeutic use*; D011652:Pulmonary Circulation; D012772:Shock, Septic / Q000517:prevention & control*; D013565:Sympatholytics / Q000627:therapeutic use*; D014655:Vascular Resistance
D000317:Adrenergic alpha-Antagonists; D005021:Ethylamines; D009946:Organothiophosphorus Compounds; D010756:Phosphoric Acids; D013565:Sympatholytics